Your browser doesn't support javascript.
loading
Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid Leukemia Based on Integrating Network Pharmacology and Molecular Docking.
Li, Hong-Xing; Jing, Yuan-Xue; Chai, Yi-Hong; Sun, Xiao-Hong; He, Xiao-Xia; Xue, Shi-Long; Xi, Ya-Ming; Ma, Xiao-Ling.
Afiliação
  • Li HX; The First Clinical Medical College, Lanzhou University, Lanzhou, 730000, China.
  • Jing YX; Reproductive Medical Center, The First Hospital of Lanzhou University, Lanzhou, 730000, China.
  • Chai YH; The First Clinical Medical College, Lanzhou University, Lanzhou, 730000, China.
  • Sun XH; Reproductive Medical Center, The First Hospital of Lanzhou University, Lanzhou, 730000, China.
  • He XX; The First Clinical Medical College, Lanzhou University, Lanzhou, 730000, China.
  • Xue SL; The First Clinical Medical College, Lanzhou University, Lanzhou, 730000, China.
  • Xi YM; Reproductive Medical Center, The First Hospital of Lanzhou University, Lanzhou, 730000, China.
  • Ma XL; The First Clinical Medical College, Lanzhou University, Lanzhou, 730000, China.
Anticancer Agents Med Chem ; 23(16): 1838-1847, 2023.
Article em En | MEDLINE | ID: mdl-37246327
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Leucemia Mielogênica Crônica BCR-ABL Positiva Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Leucemia Mielogênica Crônica BCR-ABL Positiva Idioma: En Ano de publicação: 2023 Tipo de documento: Article